Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
�Glipizide 10 mg po daily
�HCTZ 25 mg daily
�Atenolol 25 mg po daily
�Hydralazine 25 mg qid
�Simvastatin 80 mg daily
�Verapamil 180 mg CD daily
select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
Write an explanation of how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from this case . Then, describe how changes in the processes might impact the patient�s recommended drug therapy. Finally, explain how you might improve the patient�s drug therapy plan.
Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
�Chapter 19, �Hypertension� (pp. 230�246)
Chapter 20, �Hyperlipidemia� (pp. 247�262) Chapter 21, �Chronic Stable Angina� (pp. 263�277) Chapter 49, �Anticoagulation Disturbances� (pp. 764�803)